Navigation Links
Parkinson's Drugs Could Increase Heart Disease Risk

Some drugs used in the treatment of Parkinson's appear to increase the risk of heart valve disease, says a new study.//

Parkinson's disease is a degenerative disorder of the central nervous system that often impairs motor skills and speech.

Heart valves are one-way valves that keep blood flowing in the right direction through the heart. If people have problems with their heart valves then blood may not move the way it should.

The drugs used for the treatment of Parkinson's disease include pergolide, marketed as Permax, and cabergoline, sold as Dostinex, reported the online edition of health magazine WebMD.

Two studies published in the Jan 4 issue of the New England Journal of Medicine involved more than 11,000 patients prescribed anti-Parkinson's drugs from Britain registered in a nationwide database.

The studies compared treatment histories among Parkinson's disease patients who did and did not develop heart valve disease.

The rate of heart valve disease was seven times higher among pergolide-treated patients and five times higher among patients being treated with cabergoline.

"We showed that treatment with either pergolide or cabergoline for more than six months was strongly associated with an increase in valve-related heart disease," researcher Edeltraut Garbe said.

Source-IANS
'"/>




Page: 1

Related medicine news :

1. Evidence Links Protein Damage to Neurodegenerative diseases like Parkinsons and Alzheimers
2. Link between Constipation and Parkinsons Disease
3. Alternative therapies popular with Parkinsons patients
4. Poisonous Parkinsons molecule discovered
5. Cell transplants used to fend off Parkinsons symptoms
6. Coenzyme Q10 may reduce risk of Parkinsons disease
7. Vitamin E rich diet guards from Parkinsons
8. New hope for patients with Parkinsons disease
9. Parkinsons disease as a result of Head injuries
10. Homocysteine The Cause Of Depression In Patients With Parkinsons
11. Stopping The Progression Of Parkinsons Disease
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/7/2016)... ... December 07, 2016 , ... ... Business Brilliance Awards under the Best New Product Launch category. Gensuite’s entry on ... user experience. , BOC Global Events & Training Group is a professional event ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... “Walking With ... of stories that will inspire the reader to be aware of God's direction in ... of published author, Sanford Smith, retired teacher and active church leader. , ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... NuevaCare, a ... Peninsula region, is proud to announce new city-specific pages as part of its ambitious ... the elderly, they often look, first, for local agencies serving their city. The new ...
(Date:12/6/2016)... ... December 06, 2016 , ... Individuals who seek to reduce ... drinking more water or limiting their exposure to the sun, according to a November ... group Beverly Hills Physicians (BHP) notes that, while preventive measures to help keep ourselves ...
(Date:12/6/2016)... ... 06, 2016 , ... Mount Sinai Health System today announced the creation of ... can confer and order 3D models for their cases. Virtual reality, simulation, and ... times. This resource will be the first of its kind catering to the ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... 2016 United Kingdom Ophthalmic Diagnostic Equipment ... new report, "United Kingdom Ophthalmic Diagnostic Equipment Market ... the United Kingdom Ophthalmic Diagnostic Equipment market. The ... volume (in units) and average prices (USD) within ... Ultrasound Imaging Systems, Corneal Topography Systems, Ophthalmoscopes, Perimeters, ...
(Date:12/5/2016)... -- Spain Glaucoma Surgery Devices Market Outlook to 2022 ... Devices Market Outlook to 2022", provides key market data ... provides value, in millions of US dollars, volume (in ... Canaloplasty Micro Catheters and Glaucoma Drainage Devices. The ... for each of these market segements, and global corporate-level ...
(Date:12/5/2016)... -- Sangamo BioSciences, Inc. (Nasdaq: SGMO ), the ... and manufacturing data that support SB-525, its gene therapy program ... of the American Society of Hematology (ASH) being held in ... 2016. "We have developed an improved gene therapy ... highly competitive, and we remain on track to file an ...
Breaking Medicine Technology: